Metaglip side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Metaglip. Common side effects include blood glucose increased among females, and blood glucose increased among males.
The phase IV clinical study is created by eHealthMe based on 618 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
618 people who take Metaglip and have side effects are studied.
What is Metaglip?
Metaglip has active ingredients of glipizide; metformin hydrochloride. It is used in type 2 diabetes. Currently, eHealthMe is studying from 625 Metaglip users.
Number of Metaglip reports submitted per year:
Metaglip side effects by time on the drug *:
Metaglip side effects by gender *:
Metaglip side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Metaglip?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on glipizide; metformin hydrochloride (the active ingredients of Metaglip) and Metaglip (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Metaglip:
- Metaglip (625 reports)
All Metaglip side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xyrem and Uptravi drug interaction - 4 seconds ago
- Xyrem and Xeljanz drug interaction - 5 seconds ago
- Trileptal and Symbicort drug interaction - a minute ago
- Zetia and Canasa drug interaction - a minute ago
- Januvia and Abnormal Dreams - a minute ago
- Clonazepam and Canasa drug interaction - a minute ago
- Pomalyst and Fish Oil drug interaction - a minute ago
- Vioxx and Peptic Ulcer Aggravated - 2 minutes ago
- Diclofenac Sodium and Nephritis Interstitial - 2 minutes ago
- Stribild and Weight Decreased - 2 minutes ago